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ENDOCRINE FACTORS IN PEPTIC ULCER'
BOY FRAME, M.D.**

The concept that the endocrine glands influence the pathogenesis of peptic ulcer is
recent in origin. Only 10 years have passed since the delineation of the ZollingerEllison syndrome, which undoubtedly served as a major stimulus to the study of
endocrine influence in peptic ulcer. The incidence of peptic ulcer in the general
population is not known for certain and, therefore, it is difficult to say whether the
incidence of peptic ulcer is increased or decreased in various endocrine disorders. For
purposes of discussion, a 5 to 10% incidence of peptic ulcer in the general population
is assumed, a figure derived from postmortem studies of this problem.'
Physicians should not make peptic ulcer a final diagnosis, but should instead
try to ascertain initiating and aggravating factors. Table I lists areas of study that
have received attention as possible factors in the pathogenesis of peptic ulcer.
Table I
Areas of Study in Pathogenesis of Peptic

Ulcer

1) Acid-peptic influence
2)

Mucosal-protective barrier (tissue resistance)

3)

Genetic factors

4)

Effects of drugs

5)

Effect of chronic lung disease

6)

Relation to cirrhosis of the liver and chronic pancreatitis

7)

Endocrine influence

In the past, factors stimulating gastric acidity have been investigated to the
neglect of those inhibiting acid formation. This is understandable since it has been
more difficult to arrange experiments for study of the latter. Another problem has
been the inability to completely isolate excitatory stimuli of gastric secretion from
inhibitory stimuli. I n addition, the experimental models and animal species used for
study have not always been easy to relate to human peptic ulcer disease.
'Presented in part at a panel discussion on "Pathophysiologic Considerations in the Therapy of
Peptic Ulcer" in a course sponsored by the American College of Physicians, University of Kentucky
Medical Center, Lexington, Kentucky, Nov. 17, 1965.
**Fifth Medical Division.
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The investigation of factors that protect the gastric mucosa from acid peptic
digestion has heretofore received little attention. This again is understandable since
it has been easier to study the chemistry and physiology of gastric acidity than of
gastric mucus. More recently attempts have been made to evaluate the role of
gastric mucus and tissue resistance in the causation of peptic ulcer.^ While it is
true that the acid-peptic factor is of prime importance in the development of peptic
ulcer, factors that normally protect the gastric mucosa from peptic ulceration as
well as the intrinsic tissue resistance in the gastric mucosa may be equally important.
Peptic ulcer occurs frequently in siblings, but this in itself does not prove a
genetic factor since family environment has an effect. However, the high incidence
of blood group O among peptic ulcer patients supports the role of a genetic influence.^
Each person appears to be individually and genetically endowed with a prescribed
number of gastric parietal cells. This number is increased in the presence of an
ulcer diathesis and is the final common pathway under the influence of various
stimuli that increase and inhibit gastric secretion." I n the Zollinger-Ellison syndrome
and multiple endocrine adenoma-peptic ulcer complex, the parietal cell mass is increased, but it is not clear whether this is genetically determined or results from prolonged stimulation by gastrin arising in the ulcerogenic tumors of the pancreas.
A number of drugs have been incriminated as causing an increased incidence
of peptic ulcer. Among the more important are corticosteroids, aspirin, butazolidine,
and reserpine. While several of these have been reported to stimulate gastric secretion,
there are observations suggesting that a reduction in the protective gastric mucus also
occurs after drug administration and may be equally important'
The incidence of peptic ulcer in several disease states is higher than that observed
in the general population. For instance, peptic ulcer occurs frequently (20% in
some series) in patients with chronic obstructive lung disease. Gastric acidity is not
increased in these patients so other considerations such as decreased tissue resistance
and the chronic use of drugs such as salicylates and corticosteroids may be important.'
It has been suggested that the increased incidence of peptic ulcer observed in chronic
obstructive lung disease occurs only in those patients who have increased sweat
chloride levels, but there is uncertainty about the specificity of the sweat chloride test.
An increased incidence of peptic ulcer occurs in patients with cirrhosis of the
liver, and this incidence may be even greater following portacaval shunting. It has
been suggested that histamine formed in the intestinal mucosa is shunted past the
hver in such instances and, therefore, is not inactivated by histaminase in the hepatic
cells.' Peptic ulcer has been reported to occur more frequently in patients with
chronic pancreatitis, although a recent study in a relatively small series does not
support this contention.' In this same study, the level of gastric secretion in 19 male
patients with pancreatitis was found to be decreased from normal; this is contrary
to previous observations in animals with experimentally induced pancreatic inflammatory disease.
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In Table I I several endocrine conditions whose relationship to peptic ulcer disease
has been studied are listed in an order of increasing importance.
Table I I
Possible Endocrine Factors in Peptic Ulcer
1) Pituitary
2)

Gonads

3)

Beta cell tumors of the pancreas (insulin)

4)

Adrenals

5)

Para.thyroids

6)

Carcinoid tumors

7)

Non-beta cell tumors of the pancreas (gastrin)

8)

Multiple endocrine adenomatosis ( M E A )

Pituitary insufficiency in animals and man results in decreased gastric secretion
and acidity, which can partially be restored to normal after the administration of
thyroid, cortisone and growth hormone. Hyperfunctioning pituitary tumors are not
associated with an increased incidence of peptic ulcer, except when such tumors are
associated with other endocrine tumors, especially alpha cell tumors of the pancreas.
However, in the latter instance, the occurrence of peptic ulcer is very high even when
pituitary tumors are not a part of the multi-endocrine syndrome, which suggests that
pituitary influence is not critical in ulcer diathesis.
Further study should perhaps be given to the relationship of the gonadal activity
to peptic ulcer since there is a decreased incidence in females during the reproductive
age. However, before puberty and after the menopause the incidence of peptic ulcer
in the two sexes is about equal. Pregnancy appears to protect against the occurrence
of peptic ulcer, at least in the first two trimesters, and estrogens have actually been
used in the treatment of peptic ulcer disease.
Hypoglycemia is a potent stimulus of gastric secretion through activating centers
in the hypothalamus and brain stem, with subsequent stimulation of the vagal nerves.
However, despite this the incidence of peptic ulcer is not increased in patients with
beta cell tumors of the pancreas unless accompanied by non-beta cell hyperplasia or
adenoma formation.
There has been considerable study attempting to relate adrenocortical function
to peptic ulcer. At necropsy, the incidence of adrenal hyperplasia and adenomas is
increased threefold in patients with peptic ulcer when compared to those without
peptic ulcer. Physicians in the past have tended to minimize the importance of small
adrenal adenomas found at necropsy in a variety of medical conditions. This will
have to be reevaluated in view of the recent evidence that small adrenocortical
adenomas are the cause of primary aldosteronism. Studies of plasma and urinary
levels of cortisone have failed to support the view that adrenal hyperfunction exists
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in patients with peptic ulcer disease, except at the time of acute ulcer exacerbation.
There is reduced gastric acidity in patients with Addison's disease and, for some
reason, replacement therapy with only small (physiologic) doses of cortisone is
associated with an increased incidence of peptic ulcer.'
It was commonly accepted in the past that peptic ulcer is a major complication
of corticosteroid therapy. Acceptance of this is less widespread at present. It is true
that administration of large doses of corticosteroids results in increased gastric acidity,
but not to levels found in the Zollinger-Ellison syndrome. The type and dose of
corticosteroid administration has relevance to the peptic ulcer tendency as does the
duration of therapy. It is hard to find controlled series when all these factors are
taken into consideration.
The incidence of peptic ulcer occurring in the natural course of various diseases
has not always been considered when studying the potential untoward effects of
corticosteroid therapy. Rheumatoid arthritis is a disease where the incidence of peptic
ulcer with or without the administration of corticosteroids appears to be the same.""
Recent experiments have demonstrated a reduction in protective gastric mucus following the administration of corticosteroids which could result in a greater exposure
of the gastric and duodenal mucosa to aggressive acid-peptic influences.' However,
if administration of corticosteroids does increase the incidence of peptic ulcer, the fact
that peptic ulcer is not increased in Cushing's disease has never been satisfactorily
answered.
During the past decade there has been considerable debate as to whether peptic
ulcer disease is increased in hyperparathyroidism. When peptic ulcer patients are
screened for underiying hyperparathyroidism, it is found in less than 1%. In one
study 4 patients with hyperparathyroidism were found when 300 consecutive peptic
ulcer patients were screened," but 1 of these patients was subsequently demonstrated
to have multiple endocrine adenomatosis and an ulcerogenic tumor of the pancreas.
When peptic ulcer occurs in patients with hyperparathyroidism, the possibility of
underlying multiple endocrine adenomatosis should always be considered. This is
especially true if the patient has primary chief cell hyperplasia rather than a single
parathyroid adenoma. Other endocrine adenomas and hyperplasia may be difficult
to exclude, even at operation and postmortem examination.
The incidence of peptic ulcer in several series of patients with hyperparathyroidism
has varied from 10 to 25%-. Such patients may have peptic ulcer symptoms and
dyspepsia without actual X-ray evidence of peptic ulcer. It is not uncommon for
such symptoms to subside after removal of a parathyroid adenoma. A study frequently
quoted is that of Ostrow in which a 10% incidence of peptic ulcer was demonstrated
in a large series of patients with hyperparathyroidism — an incidence stated to be
only slightly above that found in the general population." It should be emphasized
that many of the patients in this composite series were studied before 1950 when less
emphasis was placed on the gastrointestinal manifestations of hyperparathyroidism.
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In a postmortem study of 812 patients whh peptic ulcer, five examples of
parathyroid pathology were encountered: four of parathyroid hyperplasia and one
of parathyroid carcinoma.' This finding does not reflect the true incidence of parathyroid pathology in peptic ulcer, for the parathyroid glands are frequently overlooked
in routine necropsy. Few adequate evaluations have been made of parathyroid
pathology occurring normally or in any disease state. In the future, more careful
attention should be given to this in the postmortem examination.
A reduction in gastric secretion and acidity occurs in hypoparathyroidism and
can be corrected by intravenous calcium or by parathyroid extract. In acute experiments, intravenous calcium given to normal subjects will increase gastric secretion,
but not to the levels seen in ulcerogenic tumors of the pancreas." While reports
vary, no evidence proves that gastric secretion is altered during chronic hyperparathyroidism; removal of a parathyroid adenoma does not result in any significant
reduction of gastric secretion. Menge reports that parathyroid extract given to rats
will increase the production of gastric mucus which theoretically might protect against
the formation of peptic ulcer. Additional observations in the same laboratory demonstrated that parathyroid extract offered protection against corticosteroid-induced
ulcers.'" Therefore, if the incidence of peptic ulcer is increased in hyperparathyroidism,
the absence of gastric hypersecretion and the presence of increased gastric mucus
suggest other operative mechanisms. As mentioned previously, at least some of
these patients have underlying polyendocrine involvement and ulcerogenic tumors
of the pancreas.
In a report of patients with intestinal carcinoids, 8 of 21 had peptic ulcer." This
is somewhat surprising in view of the fact that the administration of serotonin reduces
gastric secretion. It is possible, however, that intestinal carcinoids may be the source
of gastrin which might have an ulcerogenic influence. The difficulty in differentiating
alpha cell tumors of the pancreas from carcinoid tumors of the intestinal tract is
well known. Analysis of intestinal carcinoids for gastrin-like substances would be of
interest to help clarify this reported high incidence of peptic ulcer.
The Zollinger-Ellison syndrome is now well established and here there is a
reasonable explanation for the high incidence of multiple and intractable peptic
ulcers. In both the Zollinger-Ellison and multiple endocrine adenomatosis syndromes,
a gastrin-like substance has been isolated from the pancreatic tumors which causes
gastric hypersecretion when injected into animals. Patients with the Zollinger-Ellison
syndrome have a high incidence of other endocrine adenomas and hyperplasia which
may become apparent only after many years of observation."
In conclusion, proof is lacking that increased function of the pituitary, adrenals,
parathyroids or the beta cells of the pancreas enhances the incidence of peptic ulcer
found in the general population. It is possible that normal function of these glands
is necessary in a permissive role for the influence of other ulcerogenic factors. On
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the other hand, the high concentration of gastrin in certain non-beta cell tumors
of the pancreas offers an excellent explanation for the increased incidence of peptic
ulcer disease in the Zollinger-Ellison syndrome and the multiple endocrine adenomapeptic ulcer complex.
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